Article
Potential association of genetically predicted lipid and lipid-modifying drugs with rheumatoid arthritis: A Mendelian randomization study.
PloS one - 1 Jan 2024
Huang Zhican, Cui Ting, Yao Jin, Wu Yutong, Zhu Jun, Yang Xin, Cui Li, Zhou Haiyan
Abstract excerpt
BACKGROUND: Past studies have demonstrated that patients diagnosed with rheumatoid arthritis (RA) often exhibit abnormal levels of lipids. Furthermore, certain lipid-modifying medications have shown effectiveness in alleviating clinical symptoms associated with RA. However, the current understanding of the causal relationship between lipids, lipid-modifying medications, and the risk of developing RA remains...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
